関連文献

Clinical significance of tubular and podocyte biomarkers in acute kidney injury.

Clin Exp Nephrol. 15(2): 220-225, 2011.PubMed

Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit.

Crit Care Med. 39(11): 2464-2469, 2011.PubMed

Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury.

Crit Care Med. 38(10): 2037-2042, 2010PubMed

Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage.

Am J Pathol. 174(6): 2096-2106, 2009.PubMed

Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury.

Am J Pathol. 174(4): 1203-1211, 2009.PubMed

Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury.

Am J Pathol. 174(4): 1154-1159, 2009.PubMed

Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.

Shock. 31(5): 454-459, 2009.PubMed

Urinary human L-FABP is a potential biomarker to predict COX-inhibitor-induced renal injury.

Nephron Exp Nephrol. 108(1): e19-26, 2008.PubMed

Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery.

Kidney Int. 73(4): 465-472, 2008.PubMed

Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.

Kidney Int. 73(12): 1374-1384, 2008.PubMed